Benign prostatic hyperplasia phytotherapy

Carraro JC, Raynaud JP, Koch G, et al. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia a randomized international study of 1098 patients. Prostate 4 231-240, 1996. 

SR108 Lowe, P. C., and ]. C. Ku. Phytotherapy in treatment of benign prostatic hyperplasia a critical review. Urology 1996 48(1) 12-20. 

SR109 Odenthal, K. P. Phytotherapy of benign prostatic hyperplasia (BPH) with Cucurbita, Hypoxis, Pygeum, Urtica and Sabal serrulata (Serenoa repens). Phytother Res 1996 10 S141-S143. 

Carraro JC, Raynaud JP, Koch G, Chisholm GD, Di Silverio F, Teillac P, Da Silva FC, Cauquil J, Chopin DK, Hamdy FC, Hanus M, Hauri D, Kalinteris A, Marencak J, Perier A, Perrin P. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia a randomized international study of 1,098 patients. Prostate I996 29(4) 23 I K). 

Medicinal herbs, or phytotherapy, have been used extensively for benign prostatic hyperplasia in Europe and are being used more commonly in the U.S. Sales of herbal medicine reached 4 billion in the U.S. in 1998, and sales of saw palmetto extract for treatment of symptoms attributable to benign prostatic hyperplasia exceeded 20 million, making it the seventh most commonly purchased medicinal herbal preparation. 

Lowe EC, Fagelman E. Phytotherapy in the treatment of benign prostatic hyperplasia An update. Urology 1999 53 671-678. 

---

See also in sourсe #XX -- [ ]

---